L-Histidine methyl ester dihydrochloride

L-Histidine methyl ester dihydrochloride is an L-histidine derivative in which the alpha-carboxyl group is esterified as a methyl ester and the amino functionality is present as a dihydrochloride salt, yielding a strongly protonated, water-compatible chiral amino acid intermediate. The imidazole side chain retains histidine's characteristic pH-responsive basicity, enabling acid/base-controlled reactivity and specific coordination or nucleophilic participation in downstream transformations. The stereogenic center at the alpha carbon preserves the L-configuration required for stereochemically consistent peptide coupling and unnatural amino acid incorporation workflows. The salt form and ester functionality make the compound well suited for protected-amino-acid style synthesis, where controlled deprotonation, nucleophilic acyl substitution, and subsequent ester hydrolysis or conversion can be used to access peptide building blocks and functional intermediates.

1. Peptide Synthesis

L-Histidine methyl ester dihydrochloride supports peptide building block preparation where the ester-protected carboxyl group can be coupled into amide-forming sequences after appropriate conversion to an activated acid or after controlled deprotonation of the imidazolium side chain. The L-stereocenter aligns with standard peptide coupling stereochemical requirements, while the imidazole can be managed through pH modulation or temporary protection strategies to minimize side reactions during coupling. The dihydrochloride salt form facilitates handling and consistent reactivity in peptide assembly workflows that rely on predictable protonation states. Downstream processing can include ester hydrolysis to regenerate the carboxylic acid for further rounds of peptide construction or for generating histidine-containing analogs for structure-activity relationship studies.

2. Amino Acid Derivatization

L-Histidine methyl ester dihydrochloride functions as a chiral amino acid ester intermediate for derivatization chemistry targeting the imidazole side chain and the alpha-functional groups. The methyl ester can be transformed into carboxylic acid derivatives, activated esters, or amide derivatives, enabling stepwise access to histidine-based intermediates used in fine chemical synthesis and medicinal chemistry programs. The imidazole ring can participate in nucleophilic substitution, coordination-driven transformations, or selective functional group interconversions that preserve stereochemical integrity at the alpha carbon. The salt form supports reproducible handling during derivatization sequences, producing downstream compounds suitable for peptide analog construction and biochemical research intermediate preparation.

3. Chemical Biology Probes

L-Histidine methyl ester dihydrochloride is applicable to chemical biology workflows that require histidine-like recognition elements for probe synthesis and molecular scaffolding. The imidazole side chain provides a chemically distinct handle for conjugation strategies that exploit pH-dependent protonation and metal coordination behavior, while the ester and amino functionalities enable conversion into coupling-ready forms. The L-configuration supports stereochemically defined incorporation into peptide mimics, enabling consistent orientation of functional groups in binding studies. The resulting histidine-containing intermediates can be used to generate labeled or modified biomolecule fragments for enzyme studies, receptor interaction mapping, and mechanistic investigations of imidazole-mediated chemical recognition.

4. Protein Engineering Studies

L-Histidine methyl ester dihydrochloride can serve as a chiral precursor for histidine-modified amino acid derivatives used in protein engineering and site-specific modification strategies. The imidazole side chain provides a chemically responsive motif that can be tuned through derivatization, allowing access to analogs that mimic or alter histidine's protonation behavior in protein microenvironments. The ester-to-acid conversion capability supports downstream incorporation into peptide segments used for protein fragment assembly or for generating modified residues in synthetic protein workflows. The compound's stereodefined alpha carbon enables construction of histidine-containing sequences that maintain stereochemical fidelity required for structure-function studies.

5. Pharmaceutical Intermediate Preparation

L-Histidine methyl ester dihydrochloride is suitable for pharmaceutical intermediate preparation where histidine-derived fragments are required for synthetic routes to peptidomimetics and heteroatom-rich scaffolds. The methyl ester can be used as a controlled carboxyl protecting strategy during multi-step synthesis, while the dihydrochloride salt supports handling of the amino functionality prior to conversion into coupling partners or activated derivatives. The imidazole side chain can be carried through synthetic sequences with protonation-state management, enabling selective transformations that lead to amide, urea, or other nitrogen-containing linkages. Downstream formation of histidine-containing intermediates supports process chemistry and fine chemical synthesis programs that require stereochemically consistent amino acid building blocks.

6. Process Chemistry Intermediate

L-Histidine methyl ester dihydrochloride can be employed in process chemistry as a stable, chiral amino acid ester intermediate for scalable manufacturing of protected amino acid derivatives and peptide coupling precursors. The dihydrochloride salt form improves aqueous handling and can simplify feed preparation, while the methyl ester provides a predictable functional group for controlled hydrolysis or activation in later stages. The maintained L-configuration supports stereospecific downstream transformations, including conversion to carboxylic acid forms used for amide bond formation and iterative peptide building block preparation. The imidazole side chain enables downstream functionalization routes that can be integrated into industrial chemical manufacturing workflows for specialty chemical production and amino acid derivative supply.

1. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

2. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

3. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

5. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury